Longer treatment duration, using semaglutide, higher percentage body fat, and nondiabetic status may be associated with better weight reduction.

Clinicians managing kidney transplant candidates with pulmonary hypertension need to be aware of possible excess risks.

Fifteen of 20 HLA-matched living donor recipients achieved the primary end point of being immunosuppression-free for more than two years.

Topline data were announced from a phase 3 trial that evaluated baxdrostat in patients with uncontrolled or treatment resistant hypertension.

Chemotherapy can increase mutation burden and change the cell population structure of normal blood, researchers found.

Standard IPC measures enabled safe provision of dialysis to patients with C. auris colonization or infection, without transmission.

Although progress has been made in improving kidney transplant access for women in the US, there is still much room for improvement.

The FDA has granted RMAT designation to detalimogene voraplasmid for the treatment of high-risk, BCG-unresponsive, NMIBC with CIS.

The U.S. Centers for Disease Control and Prevention (CDC) estimates that 25 states are seeing growth in COVID cases as a summer wave appears to be starting, CBS News reported.

The approval was supported by data from the randomized, double-blind, placebo-controlled, event-driven phase 3 FINEARTS-HF study.

A trial testing a nerve-sparing (NeuroSAFE) technique in radical prostatectomy may improve patient-reported outcomes.

Total Mood Disturbance scores significantly decreased in patients who were randomized into receiving Mindfulness-Based Cancer Recovery and in all patients who received Tai Chi/Qijong treatment.